Amnesty: Vaccine manufacturers ‘fuelling human rights crisis’
Share article:
Share article:

Amnesty: Vaccine manufacturers ‘fuelling human rights crisis’

Photo by Spencer Davis on Unsplash

The manufacturers of the main Covid-19 vaccines are “fuelling an unprecedented human rights crisis” thanks to their policies on intellectual property rights, according to a new report by Amnesty International.

The five vaccines currently in circulation are made by six companies – AstraZeneca, Pfizer, BioNTech, Johnson & Johnson, Moderna and Novavax. Each one of those companies, Amnesty reports, have failed to meet their human rights responsibilities.

For example, the companies have each to a greater or lesser extent failed to take part in a coordinated initiative to increase the worldwide availability of vaccines and have actively resisted proposals to share technology and lift intellectual property rights on other countries producing their vaccines.

Not only detrimental to countries with less access to vaccines, this attitude jeopardises the global fight against the pandemic. By restricting access to vaccines for swathes of the global population, the likelihood of more resistant coronavirus variants developing in these regions greatly increases: posing a risk to those developed countries where vaccination campaigns have so far been effective.

If labs in less-developed countries were able to produce vaccines locally – and there are scientists perfectly capable of doing so – then local people would be able to be vaccinated. From a purely selfish point of view, any European visiting those countries would then be safer and would be less of a risk when returning home.

But at the moment the sharing of vaccines depends on governments, who can choose whether or not to donate, and how many doses. This distribution model is plainly insufficient to meet global demand.

Vaccinating the world is our only pathway out of this crisis. It should be time to hail these companies, who created vaccines so quickly, as heroes,” said Agnès Callamard, Amnesty International’s secretary-general.

But instead, to their shame and our collective grief, Big Pharma’s intentional blocking of knowledge transfer and their wheeling and dealing in favour of wealthy states has brewed an utterly predictable and devastating vaccine scarcity for so many others.”

In figures:

  • Out of 5.76 billion doses administered worldwide, 0.3% have gone to low-income countries, with over 79% going to upper-middle and high-income countries.
  • Just three of the six companies – BioNTech, Moderna and Pfizer – are expected to make $130 billion (€110.9 billion) combined by the end of 2022.
  • Moderna has not yet delivered a single vaccine dose to a low-income country, has provided just 12% of its vaccines to lower-middle income countries, and will not deliver the vast majority of its orders for COVAX until 2022.
  • Pfizer and BioNTech have delivered nine times more vaccines to Sweden alone than to all low-income countries combined – less than 1% of their production so far.
  • High prices mean the companies are set to earn over $86 billion in revenues by the end of 2022.
  • The publication of the report also marks the start of a new Amnesty campaign.

Today marks 100 days until the end of the year,” Callamard said.

We’re calling on states and pharmaceutical companies to drastically change course and to do everything needed to deliver two billion vaccines to low and lower-middle income countries starting now. No one should spend another year suffering and living in fear.”

Latest news

More women take police selection tests in Belgium
The selection tests to become a police inspector have more and more female participants, according to figures released by Interior Affairs Minister ...
‘Absurd’: all Brussels schools should have the same Covid rules
Several city councillors for education in Brussels are calling to abolish the "absurd" differences in coronavirus measures for Dutch-speaking and ...
Massive renovations for iconic venue in the heart of Brussels
Brussels concert hall Ancienne Belgique has announced plans to renovate the AB Café and the AB Salon and is looking for a contractor fit for the job. ...
Display of child’s room in Brussels raises awareness of foster families
An exhibit that features a fictitious child’s bedroom has been on display since Tuesday at the Place d'Armes in Namur, with the support of the ...
Test results show pupils have fallen behind in Flemish schools
Learning delays have been reported in almost all subject areas in Flanders since the start of the pandemic, a trend that continued in 2021, a ...
Belgium considers relaxing testing rules for UK travellers
At the next Consultative Committee meeting, Belgium will look into relaxing the testing and entry policy for travellers coming from the United ...
Jette libraries start giving plants away with books
Visitors to libraries in the Brussels municipality of Jette will soon be able to pick up a free plant along with a book, thanks to the new Plantotek ...
‘Do what you want, but do it as safely as possible,’ experts warn
As the daily number of new coronavirus infections exceeds 3,000 for the first time since May, infectious disease expert Erika Vlieghe and ...
‘We’re running dry’: Brussels teacher shortage reaches critical levels
The teacher shortage in Brussels is affecting schools across language borders, according to Brussels’ Minister for Multilingualism and Dutch ...
New coronavirus infections above 3,000 for first time since May
The number of people testing positive for coronavirus has skyrocketed to the highest rate since the start of May 2021. Between 9 and 15 October, ...
Belgium in Brief: Getting To The Airport
When I saw the news of plans for a tram line and cycle path to connect Brussels' outskirts to the airport, my first reaction was sheer joy.  Let ...
EU should invest €5 trillion in climate plan, says State Secretary for Economic Recovery
The European Union must invest €5 trillion in its climate plan over the next decade to "retain its credibility as a political project," according ...